clinical and serological remission following autologous bone marrow transplantation which permitted reduction and withdrawal of immunosuppressive medication until she We describe a patient with longstanding steroid-dependent systemic lupus erythematosus (SLE) in whom clinideveloped immune thrombocytopenia 3 years post-BMT. cal and serological remission was achieved following high-dose therapy and autologous bone marrow rescue for high-grade non-Hodgkin's lymphoma. However, 3
ing months. However, between April 1991 and May 1992 Resolution of autoimmune disease after allogeneic BMT she underwent a series of relapses which were treated with is well reported 7, 8 but it is unclear whether this effect is increased doses of prednisone. She was maintained on attributable to intensive immunosuppression or to the prednisone 10 mg daily between exacerbations. effects of allogeneic immune reconstitution. Data on In September 1992 the patient was referred to our Unit patients with autoimmune disease following autologous with right axillary lymphadenopathy, and histology of a transplantation is limited to one series. 9 In all of these lymph node biopsy showed high-grade lymphoblastic nonpatients there was early recurrence or persistence of autoHodgkin's lymphoma (B cell type). There were no 'B' immune disease.
symptoms. Computerised tomography body scan and lumWe present the case of a patient with longstanding sysbar puncture showed no evidence of disease elsewhere and temic lupus erythematosus (SLE) who entered a prolonged a bone marrow aspirate and trephine biopsy were normal. 40 mg/day for 4 sequential days, every 28 days, she continues on maintenance steroids. Her platelet count has now Significant complications included neutropenic sepsis responding to broad-spectrum antibiotics and mucositis. A remained above 80 × 10 9 /l for 3 months. At the time ITP developed immunological markers of SLE were negative, bone marrow harvest was performed following recovery from the fifth cycle of chemotherapy which contained but subsequently in September 1996 (41 months post-ABMT) while on maintenance steroids the ANA became 1.1 × 10 8 /l nucleated cells/kg and 1.2 × 10 4 /kg CFU-GM. Controlled freezing was performed in dimethylsulphoxide positive with an anti-centromere pattern. Other autoantibodies remain negative. and the cells were stored at −140°C.
In April 1993 the patient received consolidation using Immunological disease markers before, during and after chemotherapy and autologous bone marrow transplant are 'CBV' 11 (cyclophosphamide 1.8 g/m 2 days −6 to −3, BCNU 300 mg/m 2 day −6 and VP16 200 mg/m 2 days −6 summarised in Table 1 . to −4) followed by autologous bone marrow rescue. Early complications included neutropenic sepsis, which responded to broad-spectrum antibiotics, and delayed Discussion engraftment. By day +35 post-autologous marrow reinfusion neutrophils had risen to over 0.5 × 10 9 /l but conRecent advances have significantly reduced the procedurerelated mortality and morbidity of autologous blood and tinued platelet transfusion was necessary until day +47 and occasional red cell transfusions until day +156. Further bone marrow stem cell transplantation 12 and it now seems reasonable to investigate its potential as intensified complications included: angular cheilitis which responded to anti-fungal therapy; culture positive oral herpes simplex immunomodulation for severe autoimmune diseases. The above case suggests, in contrast to the report of Euler et which responded to acyclovir; and Pneumocystis carinii pneumonia at 5 months post-transplant which was successal, 9 that significant remissions may be achieved with highdose therapy and autologous rescue, although it is also fully treated with intravenous pentamidine followed by chemoprophylaxis for a further year.
important to address why the autoimmunity re-emerged. The remission from SLE may have been achieved by Three months post-autologous BMT, laboratory assessment showed a weak positive ANA titre of 1/80, dsDNA of several mechanisms. Firstly, the high-dose cytotoxic chemotherapy would have been markedly, if not totally 1 IU/ml, RNP negative by counter immunoelectrophoresis (CIE) and negative ACA and normal complement levels.
myelo-and lympho-ablative. The preceding cyclic chemotherapy also provided significant immunosuppression, as At 1 year post-autologous BMT (April 1994) there was no clinical evidence of relapse of lymphoma or SLE. ANA, reflected by the moderate improvement in the serological parameters. There may also have been a significant contrids-DNA, RNP (by CIE) and ACA were negative and complement levels were normal. Prednisone was reduced 1 mg bution from altered immune reconstitution that is known to occur following autologous transplantation. 13 Finally, the every 3 weeks and by November 1994 had been discontinued. The patient later reported vague symptoms of lethMagrath protocol chemotherapy given prior to the bone marrow harvest may have also been responsible for moduargy and some stiffness of the fingers without arthritis. Clinical examination was normal and disease markers were lation of immune function and composition of the graft, a factor which may have influenced outcome. The mechnegative. The symptoms were attributed to steroid withdrawal. A trial of prednisone 10 mg daily relieved the anism of the autoimmune disease in our case deserved consideration. As immunological memory is considered to symptoms and the dose was subsequently reduced more gradually without recurrence of similar symptoms. reside in T lymphocytes, recurrence of autoimmune disease could occur due to the persistence of T lymphocytes By mid-1995, the patient was steroid independent and there was no subjective or objective evidence of recurrence through high-dose therapy. This occurs as demonstrated by the mixed T lymphocyte chimerism found after allogeneic of SLE or lymphoma. Laboratory investigations showed negative ANA, dsDNA, RNP (by CIE), ACA, direct BMT in a significant proportion of patients. 14 The persistence of other cells important in SLE, such as monocytes Coombs' test, normal ESR and complement levels.
The patient remained well off steroids with no laboratory and B lymphocytes, 15 may have been important. If persistence of autoreactive cells were to be the main factor in evidence of SLE until March 1996 when she developed /l since October 1996 why the remission in this case was significantly longer than following six courses of monthly dexamethasone which has similar cases which received high-dose therapy followed by now been discontinued. Maintenance prednisone has been peripheral blood stem cell rescue. 9 Techniques are available reduced from 8 mg/day to 1 mg on alternate days over this for separating lymphocytes from haemopoietic progenitors period. The ANA is now 1/320 with other recent estiand stem cells. 17 The degree of lymphocyte depletion achimations of ACA and C4 being 2 and 0.18 g/l respectively. eved by various methods sufficient to prevent regrowth of The DCT remains negative and haemoglobin, reticulocytes, putative autoreactive lymphocyte clones is not yet estab-WBC, LDH and bilirubin remain normal. lished, although experience from graft-versus-host disease suggests that harvests should be depleted to less than 10 5 T cells/kg. 18 However, the question of whether autologous Acknowledgements graft manipulation can significantly prolong remission can only be answered in carefully constructed clinical trials.
We would like to acknowledge the following for their contriFinally, the presentation of autoimmunity may have been Although it seems more likely that the re-presentation of following autologous transplantation. 21 The recent estab- this treatment modality offers promise for the future. Clini-
